DK0894130T3 - Modulatorer af TNF receptor associeret faktor (TRAF), deres fremstilling og anvendelse - Google Patents

Modulatorer af TNF receptor associeret faktor (TRAF), deres fremstilling og anvendelse

Info

Publication number
DK0894130T3
DK0894130T3 DK97914534T DK97914534T DK0894130T3 DK 0894130 T3 DK0894130 T3 DK 0894130T3 DK 97914534 T DK97914534 T DK 97914534T DK 97914534 T DK97914534 T DK 97914534T DK 0894130 T3 DK0894130 T3 DK 0894130T3
Authority
DK
Denmark
Prior art keywords
traf
modulators
preparation
associated factor
tnf receptor
Prior art date
Application number
DK97914534T
Other languages
English (en)
Inventor
David Wallach
Nikolai Malinin
Mark Boldin
Andrei Kovalenko
Igor Mett
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11780096A external-priority patent/IL117800A0/xx
Priority claimed from IL11913396A external-priority patent/IL119133A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0894130T3 publication Critical patent/DK0894130T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK97914534T 1996-04-02 1997-04-01 Modulatorer af TNF receptor associeret faktor (TRAF), deres fremstilling og anvendelse DK0894130T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11780096A IL117800A0 (en) 1996-04-02 1996-04-02 Modulators of TNF receptor associated factor (TRAF) their preparation and use
IL11913396A IL119133A0 (en) 1996-08-26 1996-08-26 Modulators of TNF receptor associated factor (TRAF) their preparation and use
PCT/IL1997/000117 WO1997037016A1 (en) 1996-04-02 1997-04-01 Modulators of tnf receptor associated factor (traf), their preparation and use

Publications (1)

Publication Number Publication Date
DK0894130T3 true DK0894130T3 (da) 2008-01-07

Family

ID=26323248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97914534T DK0894130T3 (da) 1996-04-02 1997-04-01 Modulatorer af TNF receptor associeret faktor (TRAF), deres fremstilling og anvendelse

Country Status (23)

Country Link
US (2) US7485456B1 (da)
EP (1) EP0894130B1 (da)
JP (1) JP4180114B2 (da)
CN (1) CN1197966C (da)
AT (1) ATE380866T1 (da)
AU (1) AU732793B2 (da)
BG (1) BG64755B1 (da)
BR (1) BR9708518A (da)
CA (1) CA2250085C (da)
CZ (3) CZ299094B6 (da)
DE (1) DE69738370T2 (da)
DK (1) DK0894130T3 (da)
EA (1) EA004309B1 (da)
EE (1) EE04783B1 (da)
ES (1) ES2294796T3 (da)
HK (1) HK1018910A1 (da)
HU (1) HU226328B1 (da)
NO (1) NO327054B1 (da)
NZ (1) NZ331902A (da)
PT (1) PT894130E (da)
SK (3) SK287085B6 (da)
UA (1) UA71889C2 (da)
WO (1) WO1997037016A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
JP2003525567A (ja) * 1997-11-07 2003-09-02 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 分泌蛋白およびそれらをコードするポリヌクレオチド
AU2877899A (en) * 1998-02-27 1999-09-15 Regents Of The University Of California, The A novel inhibitor of the inflammatory response induced by tnfalpha and il-1
EP1075519B1 (en) * 1998-05-06 2005-11-09 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Inhibitors of nf-kb activation
US20020099169A1 (en) * 1998-08-18 2002-07-25 Basf Aktiengesellchaft Tpl-2/cot kinase and methods of use
IL131719A0 (en) * 1999-09-02 2001-03-19 Yeda Res & Dev Iren protein its preparation and use
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
KR20020069140A (ko) * 2001-02-21 2002-08-29 주식회사 코메드 종양 괴사 인자 수용체 관련 인자 6 억제 단백질
WO2003000280A2 (en) 2001-06-22 2003-01-03 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Abin-mediated hepatitis protection
PT1499729E (pt) 2002-04-18 2011-09-06 Yeda Res & Dev Derivados da enzima de indução de nf-kappab, sua preparação e utilização
ATE509034T1 (de) * 2003-10-07 2011-05-15 Yeda Res & Dev Antikörper gegen nik, deren herstellung und verwendung
IL158287A0 (en) 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
JP5039383B2 (ja) * 2003-11-30 2012-10-03 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド 免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法
IL173104A0 (en) * 2006-01-12 2006-06-11 Yeda Res & Dev Siva and ubiquintination
EP2316030B1 (en) 2008-07-25 2019-08-21 Wagner, Richard W. Protein screeing methods
GB201012420D0 (en) 2010-07-23 2010-09-08 Univ Erasmus Medical Ct Foetal heamoglobin inhibitor
US9029506B2 (en) 2010-08-25 2015-05-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
CN105177032B (zh) * 2010-09-01 2019-05-10 山东新时代药业有限公司 新型人肿瘤坏死因子受体-Fc融合基因及其产物蛋白
AR085908A1 (es) 2011-03-16 2013-11-06 Hoffmann La Roche DERIVADOS DE 3-BUTIN-2-OL Y DE CARBONITRILO CON ACTIVIDAD INHIBIDORA DE LA QUINASA INDUCTORA DE NF-kB (NIK)
PT2726101T (pt) 2011-06-30 2018-11-21 Genzyme Corp Inibidores da ativação de células t
EP2734232B1 (en) 2011-07-19 2017-11-01 Philogen S.p.A. Sequential anti-ctla4 and targeted il-2 therapy
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
US10441654B2 (en) 2014-01-24 2019-10-15 Children's Hospital Of Eastern Ontario Research Institute Inc. SMC combination therapy for the treatment of cancer
CN105986001B (zh) * 2015-02-12 2019-12-03 上海交通大学 一种基于膜结合蛋白和荧光互补的高通量猎物拮抗剂筛选方法
CA3135032A1 (en) 2019-04-03 2020-10-08 Genzyme Corporation Anti-alpha beta tcr binding polypeptides with reduced fragmentation
US12054552B2 (en) 2022-09-21 2024-08-06 Sanofi Biotechnology Humanized anti-IL-1R3 antibody and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641876A (en) * 1990-01-05 1997-06-24 Cornell Research Foundation, Inc. Rice actin gene and promoter
AU705777B2 (en) * 1995-08-02 1999-06-03 Teresa J. Ingram Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome
AU6692996A (en) 1995-08-08 1997-03-05 Tularik Inc. Inhibitors of apoptosis
US5804412A (en) * 1996-04-01 1998-09-08 The Regents Of The University Of California Nucleic acids encoding sorting nexins and methods of using same
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
WO1997042299A1 (en) 1996-05-08 1997-11-13 Henkel Corporation Alkyl polyglycoside ether carboxylates
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein

Also Published As

Publication number Publication date
CN1221449A (zh) 1999-06-30
ES2294796T3 (es) 2008-04-01
WO1997037016A1 (en) 1997-10-09
EP0894130B1 (en) 2007-12-12
EE04783B1 (et) 2007-02-15
CN1197966C (zh) 2005-04-20
AU732793B2 (en) 2001-05-03
US7485456B1 (en) 2009-02-03
PT894130E (pt) 2008-01-14
CA2250085C (en) 2009-10-20
CZ318398A3 (cs) 1999-05-12
NO984551L (no) 1998-11-24
HU226328B1 (en) 2008-09-29
DE69738370T2 (de) 2008-12-04
SK287889B6 (sk) 2012-03-02
ATE380866T1 (de) 2007-12-15
EA199800885A1 (ru) 1999-04-29
JP2000507826A (ja) 2000-06-27
NO327054B1 (no) 2009-04-14
HK1018910A1 (en) 2000-01-07
CZ298866B6 (cs) 2008-02-27
BG64755B1 (bg) 2006-02-28
SK136198A3 (en) 1999-05-07
JP4180114B2 (ja) 2008-11-12
US20090291888A1 (en) 2009-11-26
BR9708518A (pt) 1999-08-03
SK287085B6 (sk) 2009-11-05
CZ299094B6 (cs) 2008-04-23
CA2250085A1 (en) 1997-10-09
HUP9902429A2 (hu) 1999-10-28
CZ299682B6 (cs) 2008-10-15
EP0894130A1 (en) 1999-02-03
HUP9902429A3 (en) 2001-11-28
BG102817A (en) 1999-05-31
EA004309B1 (ru) 2004-02-26
SK287890B6 (sk) 2012-03-02
EE9800322A (et) 1999-04-15
US8236507B2 (en) 2012-08-07
NZ331902A (en) 2000-02-28
DE69738370D1 (de) 2008-01-24
NO984551D0 (no) 1998-09-29
UA71889C2 (uk) 2005-01-17
AU2175597A (en) 1997-10-22

Similar Documents

Publication Publication Date Title
DK0894130T3 (da) Modulatorer af TNF receptor associeret faktor (TRAF), deres fremstilling og anvendelse
NO960767L (no) Protocadherinproteiner og deres anvendelse
PT917571E (pt) Gene relacionado com agouti
IL193886A0 (en) Antibodies that bind to ldcam sequences
NL300129I2 (nl) TFN-bindende eiwitten
CY1108175T1 (el) ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR
WO2002036769A3 (en) Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
DK1141286T3 (da) Kæde af cytokinreceptorer
DK0963377T3 (da) Interleukin-19
IE811049L (en) Cloned fmdv antigens
WO2000024771A3 (en) Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
IL161296A0 (en) Glycosylphosphatidylinositol containing polypeptides
ATE408687T1 (de) Semaphorin polypeptide
AU3667397A (en) Recombinant n-proteinase, and the production, methods and uses thereof
MX9605531A (es) Modulador de receptores de la superfamilia de factor de necrosis tumoral/factor de crecimiento de nervio y receptores oligomericos solubles de la superfamilia de factor de necrosis tumoral/factor de crecimiento necrotico.
AR008064A1 (es) Una proteina ligante del factor de necrosis tumoral truncada de bajo peso molecular (tnf bp), un polinucleotido codificante de dicha proteina, un vector, una celula hospedante, metodos para producir dicha proteina, una composicion farmaceutica, metodo para tratar una enfermedad mediada por tnf bp y usos de dicha proteina.